 |
Paclitaxel |
|---|---|
| Trade Name | Taxol |
| Orphan Indication | AIDS-related Kaposi's sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 1997-03-25 00:00:00 |
| Sponsor | Bristol-Myers Squibb Pharmaceutical Research Institute;5 Research Parkway, P.O. Box 5100;Wallingford, Connecticut, 06492 |
